Francis Chu
Impact in
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
- Oncology top 10%
- Pancreatic and Hepatic Oncology Research
- Lung Cancer Research Studies
Papers in
- Hepatology 16
- Hepatocellular Carcinoma Treatment and Prognosis 16
- Surgery 8
- Cholangiocarcinoma and Gallbladder Cancer Studies 3
- Esophageal and GI Pathology 2
- Intraperitoneal and Appendiceal Malignancies 1
- Co-authors
- David L. Morris (24 shared papers)Terence C. Chua (19 shared papers)Akshat Saxena (15 shared papers)Winston Liauw (8 shared papers)Lourens Bester (1 shared paper)Deborah Black (3 shared papers)Tristan D. Yan (3 shared papers)Jason Behary (2 shared papers)
- Journals
- ANZ Journal of Surgery (3 papers)Annals of Surgical Oncology (3 papers)Journal of Surgical Oncology (2 papers)Liver International (2 papers)European Journal of Cancer (2 papers)
- Partner nations
- AustraliaIndiaUnited Kingdom
In The Last Decade
Francis Chu
31 papers receiving 1.4k citations
Francis Chu's Hit Papers
Peers
Comparison fields: 5 of 78
- Hepatology 453
- Oncology 370
- Epidemiology 367
- Surgery 342
- Neurology 97
Countries citing papers authored by Francis Chu
This map shows the geographic impact of Francis Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francis Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francis Chu more than expected).
Fields of papers citing papers by Francis Chu
This network shows the impact of papers produced by Francis Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francis Chu. The network helps show where Francis Chu may publish in the future.
Co-authors
The 25 scholars most cited alongside Francis Chu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma Hit paper breakdown → | 2021 | 347 |
| 2 | 2009 | 146 | |
| 3 | 2012 | 101 | |
| 4 | 2011 | 87 | |
| 5 | 2010 | 73 | |
| 6 | 2011 | 63 | |
| 7 | 2009 | 56 | |
| 8 | 2010 | 53 | |
| 9 | 2011 | 50 | |
| 10 | 2007 | 47 | |
| 11 | 2011 | 47 | |
| 12 | 2007 | 36 | |
| 13 | 2012 | 33 | |
| 14 | 2012 | 33 | |
| 15 | 2009 | 28 | |
| 16 | 2019 | 27 | |
| 17 | 2011 | 24 | |
| 18 | 2010 | 20 | |
| 19 | 2009 | 18 | |
| 20 | 2010 | 15 |
About Francis Chu
Francis Chu is a scholar working on Hepatology, Surgery, Epidemiology, Oncology and Molecular Biology, having authored 31 papers that have together received 1.4k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (16 papers), Neuroendocrine Tumor Research Advances (3 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers), Liver Disease Diagnosis and Treatment (2 papers), Esophageal and GI Pathology (2 papers), Diet and metabolism studies (1 paper), Intraperitoneal and Appendiceal Malignancies (1 paper) and Lung Cancer Research Studies (1 paper). The work is most often cited by research in Hepatology (453 citations), Oncology (370 citations), Epidemiology (367 citations), Surgery (342 citations) and Neurology (97 citations). Francis Chu has collaborated with scholars based in Australia, India and United Kingdom. Frequent co-authors include David L. Morris, Terence C. Chua, Akshat Saxena, Winston Liauw, Lourens Bester, Deborah Black, Tristan D. Yan, Jason Behary, Marlon Perera and Amany Zekry. Their work appears in journals such as ANZ Journal of Surgery, Annals of Surgical Oncology, Journal of Surgical Oncology, Liver International and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.